| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da86b7e580d52f016ffcd0634c4ea269
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bec01ff2f200bac125624ad81221976
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ddf35adbbcf5de9db484a2770c38df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_749c759afcd05a8a7edf7731232d8d34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58c2e55b357656f55779b7830c34c7da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bab966cf54c7ebecd2eb36c00b571bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_977ebb660999f345084ffad260515ff6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e58565c79f72724b1476626bd5d5b8f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-65 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-65 |
| filingDate |
2000-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8398a47bc924dbf892879184a7c86956
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9aae98db40c5ffa3ee7210215c107f1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daa6a7d39e6ab34119160a3e0af1558a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c49c076a9c03a5e95f61cd37fbd2d1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68cf11aece7c097444feb7942939ae23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_910a8f65f488e7a2040d84a9eff6ba90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_683487d037e809e948da1b3d9933f66d |
| publicationDate |
2001-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0138301-A1 |
| titleOfInvention |
(r)-3-(4-chlorobiphenyl-sulfonyl)-2-hydroxy-2-(phenylthio)methylpropionic acid and its use matrix metalloproteinase |
| abstract |
The present invention provides a compound which is (R)-3-(4-chlorobiphenyl-sulfonyl)2-hydroxy-2-(phenylthio)methylpropionic acid of formula (Ia) or a pharmaceutical acceptable salt thereof in enantiomerically pure form. The compound is an inhibitor of matrix metalloproteinases. |
| priorityDate |
1999-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |